← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Abzyme Therapeutics, Llc
Pottstown, PA
$7,558,719
Total funding
18
Grants
Funding over time
peak $1.2M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,558,719 · 18
By mechanism
R43$3,630,566 · 14
R44$3,328,339 · 2
N01$299,999 · 1
N43$299,815 · 1
Investigators at Abzyme Therapeutics, Llc
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases$831,927
R44 · FY2024 · EY
Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases$826,067
R44 · FY2025 · EY
High throughput camelid antibody screening as a drug discovery platform$750,213
R44 · FY2016 · GM
High throughput camelid antibody screening as a drug discovery platform$749,787
R44 · FY2017 · GM
Brain-cell penetrating antibodies for treatment of progressive multiple sclerosis$399,107
R43 · FY2021 · NS
Novel immune-escape uricase for treatment of hyperuricemia$299,999
R43 · FY2023 · AI
Monoclonal Antibodies to RNA-modifications$299,999
N01 · FY2018 · CA
Multi-specific long-acting antibodies for the treatment of retinal neovascular diseases$299,989
R43 · FY2019 · EY
Antibody Fragments to Improve HIV gp120 Protein Production$299,815
N43 · FY2019 · AI
Human Proteolytic Beta-Amyloid Specific Antibodies for Treatment of Alzheimers Di$282,519
R43 · FY2011 · AG
Pemphigus-specific T cell engagers for pemphigus targeted immunotherapy$280,352
R43 · FY2019 · AI
Modular antibody engineering to overcome the blood brain barrier$236,646
R43 · FY2017 · NS
Nanobodies for detecting and manipulating A to I editing enzymes and their modified RNA products$224,975
R43 · FY2014 · DA
Nanobodies for topical delivery to inhibit abnormal choroidal angiogenesis$224,935
R43 · FY2015 · EY
Development Of Arginine Linkage-Specific Antibodies$224,926
R43 · FY2017 · GM
Novel bispecific T cell engaging antibodies for treatment of Lyme disease$224,849
R43 · FY2014 · AI
High throughput approach for generating human monoclonal antibodies$224,799
R43 · FY2015 · GM
Hybridoma free multiplex approach for accelerating mouse monoclonal antibody generation$224,781
R43 · FY2015 · CA
Novel approach for rapid generation of human antibodies to RNA-modifications$224,638
R43 · FY2016 · DA
High throughput camelid antibody screening as drug discovery platform$218,085
R43 · FY2014 · GM